GGrantIndex
Sort

261,768 grants matching gene therapy

Mechanisms of Normal Tissue Toxicity From Irradiation

$1,681,212
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Salivary Gland Secretion Mechanisms During Normal And Altered Functional States

$1,681,211
Bruce J Baum · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

PPG-GENE THERAPY FOR CYSTIC FIBROSIS LUNG DISEASE

$1,681,189
Michael J. Welsh · University Of Iowa · P01 · FY2007 · HL

Therapeutic APOE2 overexpression for early Alzheimer's disease

$1,681,128
Beverly L Davidson · Children'S Hosp Of Philadelphia · U01 · FY2019 · NS

Targeting the DNA damage response in cancer therapy

$1,681,063
Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Understanding the role of circadian clocks on healthy longevity

$1,680,800
Victoria Acosta-Rodrãguez · National Institute On Aging · ZIA · FY2025 · AG

IL-13 and IL-17 dynamics in the asthmatic airway

$1,680,602
Dean Sheppard · University Of California, San Francisco · U19 · FY2014 · AI

Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-Americans

$1,680,584
Omonigho A Michael Bubu · New York University School Of Medicine · R01 · FY2025 · AG

Etiology and Treatment of Alcohol Dependence

$1,680,402
Victor M Hesselbrock · University Of Connecticut Sch Of Med/Dnt · P60 · FY2012 · AA

Signaling in the retina and retinal pigment epithelium

$1,680,317
Thomas Redmond · National Eye Institute · ZIA · FY2022 · EY

SHIPSS: Stress Hydrocortisone In Pediatric Septic Shock

$1,680,001
Michael Agus · Boston Children'S Hospital · R01 · FY2024 · HD

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection

$1,679,994
Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2025 · AI

Delivery of therapeutic genes in motor neuron disease

$1,679,896
Arthur H.m Burghes · Ohio State University · RC2 · FY2009 · NS

Immunotherapy of low grade lymphoid malignancies

$1,679,879
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Human Cell Assay Core

$1,679,849
David M Gamm · University Of Wisconsin-Madison · U19 · FY2023 · NS

Investigations of Methylmalonic Acidemia and Related Disorders

$1,679,548
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2021 · HG

RP4: Harnessing autophagy to treat tuberculosis

$1,679,254
Michael Shiloh · Ut Southwestern Medical Center · U19 · FY2021 · AI

Epigenetic Control and Genome Organization

$1,679,239
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2024 · CA

HORMONAL CONTROL OF CALCIUM METABOLISM

$1,679,104
John T Potts · Massachusetts General Hospital · P01 · FY2012 · DK

Pathobiology of Asthma

$1,679,009
Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2015 · HL

Epigenetic Control and Genome Organization

$1,678,923
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2021 · CA

OPTIMIZE - CCC - Lead Application

$1,678,874
Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2014 · HL

DNA Repair in Human Cancer-Prone Genetic Diseases

$1,678,700
Kenneth H Kraemer · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Clinical evaluation of BMS-984923 metabolism.

$1,678,603
Timothy R Siegert · Allyx Therapeutics Inc. · SB1 · FY2024 · AG

Center for Systems-level Study of Metastasis

$1,678,554
Sohail F. Tavazoie · Rockefeller University · U54 · FY2025 · CA